This week's FierceBiotech is brought to you by VERISTAT. Trouble viewing? Click here.
FDA Meeting Types - Explained
Timing, Purpose & Examples
Veristat encourages all sponsors to meet with and discuss your development plans with the United States Food & Drug Administration (FDA) throughout your development program. Early and successful interactions with the FDA can reduce both costs and time to approval.
To meet with the FDA, you will need to decide on your preferred format for the meeting (face-to-face, teleconference, or written responses), and submit a formal meeting request accompanied with or followed closely by an informational package. Once the FDA has reviewed your meeting request, they will determine whether to grant the meeting and determine the meeting format.
View our FDA Meeting Types Infographic to learn about Type A, Type B and Type C meetings – with specific insights into meeting timing, purposes and examples of each type throughout development.
Want to reach 137,000+ FierceBiotech subscribers with your own message? Contact aalcover@fiercemarkets.com or call 202-824-5074.
You are currently subscribed as newsletter@newslettercollector.com. If you no longer wish to receive communications from FierceBiotech's trusted partners, simply click here to unsubscribe. Refer to our Privacy Policy.
